Professor Duda is an inspiring scientist from Harvard Medical School, Boston, USA. We invited him to share with us some thoughts on career development in science and on current oncology topics, his area of research interest.

He has authored over 240 publications so far, of which 140 are original reports, including in premiere basic research journals such as Nature, Nature Medicine, Nature Biotechnology, Nature Genetics, Nature Precision Oncology, Cell, Cancer Cell, Science Translational Medicine, Cancer Discovery, Gut, and Hepatology and clinical journals such as Journal of Clinical Oncology and JAMA Oncology. He is a Founding Editor of the journal Surgery, Gastroenterology and Oncology, a Senior Associate Editor of the International Journal of Radiation Oncology*Biology*Physics, and an Editorial Board member for several other journals, including Clinical & Translational Radiation Oncology, Journal of Hepatocellular Carcinoma and Cancers. He is a member of the US National Cancer Institute Hepatobiliary Task Force for Immuno-Oncology Biomarkers. As a passionate supporter of the IASGO’s mission to globalize the best medical practice and knowledge all over the world, he has been coordinating, teaching and directing Postgraduate Courses, Symposia and Congresses in 28 countries in Asia, Europe, Africa and the Americas, since 2013. Since 2015, he is Secretary General of IASGO.

For his work, Dr. Duda received multiple awards, including from the AACR, Cancer Research Institute, IASGO, and Massachusetts General Hospital. He was elected as an Honorary Member of the Academy of Medical Sciences of Romania in 2012 and was inducted into the College of Fellows of the American Institute for Medical and Biomedical Engineering, representing the top 2% of the most accomplished leaders in the fields of medical and biological engineering, in 2020.